BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21958731)

  • 1. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
    Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
    Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy is associated with lower mortality among patients with severe heart failure.
    Mozaffarian D; Nye R; Levy WC
    Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.
    Sola S; Mir MQ; Rajagopalan S; Helmy T; Tandon N; Khan BV
    J Card Fail; 2005 Oct; 11(8):607-12. PubMed ID: 16230264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
    Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
    Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of statin use on heart failure mortality.
    Thambidorai SK; Deshmukh AR; Walters RW; Turner PD; Monaghan MS; Mooss AN; Hunter CB; Esterbrooks DJ; Mohiuddin SM
    Int J Cardiol; 2011 Mar; 147(3):438-43. PubMed ID: 20971517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG; Gong Y; Sykora K; Tu JV
    Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
    Horwich TB; MacLellan WR; Fonarow GC
    J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
    Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.
    Fukuta H; Sane DC; Brucks S; Little WC
    Circulation; 2005 Jul; 112(3):357-63. PubMed ID: 16009792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
    Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
    Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.
    Sicard P; Zeller M; Dentan G; Laurent Y; Touzery C; L'huillier I; Janin-Manificat L; Lorgis L; Beer JC; Makki H; Rochette L; Cottin Y;
    Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
    Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
    J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT.
    Krum H; Latini R; Maggioni AP; Anand I; Masson S; Carretta E; Ingrillì F; Pettinati G; Glazer R; Tognoni G; Cohn J
    Int J Cardiol; 2007 Jun; 119(1):48-53. PubMed ID: 17049646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.
    Charach G; George J; Roth A; Rogowski O; Wexler D; Sheps D; Grosskopf I; Weintraub M; Keren G; Rubinstein A
    Am J Cardiol; 2010 Jan; 105(1):100-4. PubMed ID: 20102899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
    Núñez J; Núñez E; Sanchis J; Bodí V; Fonarow GC; Miñana G; Palau P; Bertomeu-González V; Carratalá A; Mainar L; Chorro FJ; Llàcer A
    Int J Cardiol; 2012 Aug; 159(1):21-8. PubMed ID: 21367474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery.
    Vaduganathan M; Stone NJ; Lee R; McGee EC; Malaisrie SC; Silverberg RA; Kansal P; McCarthy PM
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1018-27. PubMed ID: 20851427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.